BioXcel Therapeutics, Inc. Financial Ratios — BTAI Stock

Profitability (USD)

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-666.52	-85.83	-82.48	-64.11	-46.55	-74.45	-128.1	-106.39	-167.91
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	- -	- -	- -	- -	- -	- -	94.67	8.7	5.43	74.45
EBITDA Margin (%)	- -	- -	- -	- -	- -	- -	-42,484.8	-12,123.26	-2,846.2	-7,783.02
Operating Margin (%)	- -	- -	- -	- -	- -	- -	-42,572	-12,146.3	-2,859.84	-7,829.75
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	- -	- -	- -	- -	- -	- -	-44,201.87	-12,974.86	-2,630.14	-10,887.38
Profit Margin (%)	- -	- -	- -	- -	- -	- -	-44,201.87	-12,974.86	-2,630.14	-10,887.38
Net Income to Common Margin (%)	- -	- -	- -	- -	- -	- -	-44,201.87	-12,974.86	-2,630.14	-10,887.38
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API Chat

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	- -	- -	- -	1	2	1	94	101	103	110
ST Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	25
LT Debt	- -	- -	- -	1	1	1	94	101	103	85
Total Debt/EBITDA	- -	-0.08	- -	-0.03	-0.02	-0.01	-0.59	-0.61	-1.6	-2.19
Net Debt/EBITDA	- -	0.11	2.13	0.97	2.6	2.18	0.63	-0.21	-1.13	-1.62
Total Debt/EBIT	- -	-0.08	- -	-0.03	-0.02	-0.01	-0.59	-0.6	-1.59	-2.18
Net Debt/EBIT	- -	0.11	2.13	0.97	2.59	2.18	0.63	-0.21	-1.12	-1.61
EBITDA to Interest Expense	- -	-2,268	- -	-1,672.25	-3,041.07	-2,665.98	-19.4	-12.57	-4.26	-2.94
EBITDA-CapEx/Interest Expense	- -	-2,268	- -	-1,715.75	-3,052.78	-2,677.1	-19.42	-12.57	-4.26	-2.94
EBIT to Interest Expense	- -	-2,268.5	- -	-1,680.05	-3,048.04	-2,673.4	-19.44	-12.59	-4.28	-2.96
Interest Expense	- -	- -	- -	- -	- -	- -	8	13	15	17
Common Equity/Total Assets	- -	-327.68	-54.43	-155.72	-63.12	-102.64	-199.91	-801.29	-1,695.83	-1,603.03
Long-Term Debt/Equity (%)	- -	- -	- -	3.83	0.68	0.5	122.22	- -	- -	- -
Long-Term Debt/Capital (%)	- -	- -	- -	-1.85	-1.02	-0.45	-29.57	-20.65	-18.75	-13.87
Long-Term Debt/Total Assets (%)	- -	- -	- -	2.83	0.64	0.46	45.58	137.09	267.55	188.49
Total Debt/Equity (%)	- -	-37.78	- -	3.83	0.79	0.63	122.64	-179.42	-110.58	-114.87
Total Debt/Capital (%)	- -	-9.12	- -	-1.85	-1.19	-0.57	-29.67	-20.73	-18.81	-17.97
Total Debt/Total Assets (%)	- -	27.38	- -	2.83	0.74	0.58	45.74	137.56	268.52	244.14
Net Debt to Equity	- -	52.55	-109.45	-120.57	-103.11	-105.1	-131.13	-62.61	-78.04	-85.04
Net Debt/Capital (%)	- -	10.41	64.23	36.82	60.84	48.81	19.7	-6.38	-12.59	-12.71
EBITDA	-2	-5	-20	-33	-82	-107	-159	-167	-64	-50
EBITDA-CapEx	-2	-5	-20	-34	-82	-107	-159	-167	-64	-50
Operating Income (Loss)	-2	-5	-20	-34	-82	-107	-160	-168	-65	-50

Liquidity (USD)

API Chat

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	- -	0.38	9.13	3.83	18	13.98	5.89	2.39	1.34	0.53
Current Ratio	0.01	0.38	9.26	4.03	18.33	14.21	6.17	2.65	1.68	0.83
Quick Ratio	- -	0.38	9.16	3.83	18	13.98	5.9	2.39	1.35	0.53
CFO/Avg Current Liab	- -	-1.65	-3.86	-4.13	-6.53	-5.76	-5.46	-5.15	-2.91	-1.51
Common Equity/Total Assets	- -	-327.68	-54.43	-155.72	-63.12	-102.64	-199.91	-801.29	-1,695.83	-1,603.03
Long-Term Debt/Equity (%)	- -	- -	- -	3.83	0.68	0.5	122.22	- -	- -	- -
Long-Term Debt/Capital (%)	- -	- -	- -	-1.85	-1.02	-0.45	-29.57	-20.65	-18.75	-13.87
Long-Term Debt/Total Assets (%)	- -	- -	- -	2.83	0.64	0.46	45.58	137.09	267.55	188.49
Total Debt/Equity (%)	- -	-37.78	- -	3.83	0.79	0.63	122.64	-179.42	-110.58	-114.87
Total Debt/Capital (%)	- -	-9.12	- -	-1.85	-1.19	-0.57	-29.67	-20.73	-18.81	-17.97
Total Debt/Total Assets (%)	- -	27.38	- -	2.83	0.74	0.58	45.74	137.56	268.52	244.14
CFO/Total Liabilities	-390.94	-93.97	-289.89	-285.36	-501.13	-462.26	-104.85	-119.04	-54.8	-41.04
CFO/CapEx	-323.5	- -	-39.73	-31.15	-209.97	-184.61	-973.68	-7,750.3	- -	- -
Altman's Z-Score	-1,055.83	-16.93	6.03	10.65	44.4	16.29	-1.57	-17.58	-28.72	-26.29

Working Capital (USD)

API Chat

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	- -	- -	- -	- -	- -	- -	3.02	8.65	22.44	3.53
Days Sales Outstanding	- -	- -	- -	- -	- -	- -	120.69	42.19	16.27	103.47
Inventory Turnover	- -	- -	- -	- -	- -	- -	0.02	0.63	1.61	0.23
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	18,113.12	575.89	227.38	1,559.04
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	0.27	0.11	0.06	0.01
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	1,356.78	3,442.71	6,510.26	27,058.49
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	16,877.04	-2,824.63	-6,266.62	-25,395.98
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	-17,992.43	-533.7	-211.11	-1,455.57
Inventories	- -	- -	- -	- -	- -	- -	2	2	1	1
Raw Materials	- -	- -	- -	- -	- -	- -	1	1	1	- -
Work In Process	- -	- -	- -	- -	- -	- -	1	1	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	1	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	- -	- -	56	238	1,002	536	602	86	15	20
- Cash & Cash Equivalents	- -	1	43	32	213	233	194	65	30	28
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	1	2	1	94	101	103	110
Enterprise Value	- -	-1	14	207	790	305	502	122	88	101
Total Capital	- -	-4	-24	-56	-137	-244	-317	-489	-547	-610
Total Debt/Capital (%)	- -	-9.12	- -	-1.85	-1.19	-0.57	-29.67	-20.73	-18.81	-17.97
Total Debt / EV	- -	-0.72	- -	- -	- -	- -	0.19	0.83	1.17	1.09
EV/Sales	- -	- -	- -	- -	- -	- -	1,339.18	88.47	38.95	156.97
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	56	238	1,002	536	602	86	15	20
Diluted Enterprise Value	- -	-1	14	207	790	305	502	122	88	101
EV per Share	- -	- -	15.02	202.92	583.14	184.79	286.81	67.06	34.81	8.25
TTM Sales	- -	- -	- -	- -	- -	- -	- -	1	2	1
TTM EBITDA	-2	-5	-20	-33	-82	-107	-159	-167	-64	-50
TTM Operating Income	-2	-5	-20	-34	-82	-107	-160	-168	-65	-50
TTM Cash Flow to Firm	-1	-2	-14	-27	-66	-82	-127	-142	-57	-41
TTM Free Cash Flow to Firm	-1	-2	-13	-26	-66	-82	-127	-142	-57	-41

Multiples (USD)

API Chat

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	- -	- -	-4.27	-9.07	-15.17	-6.56	-4.45	-0.55	-0.21	-0.34
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	- -	-1	14	207	790	305	502	122	88	101
Low Price	- -	- -	38.56	53.28	191.2	299.44	140.72	35.68	4.8	1.17
EV/Sales	- -	- -	- -	- -	- -	- -	1,339.18	88.47	38.95	156.97
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	-6.22	-4.25	-10.51	-8.5	-2.57	-2.32	-1.08	-0.46
Price/Earnings High	- -	- -	-11.18	-7.31	-18.87	-16.71	-4.15	-5.55	-2.84	-1.62
Price/Earnings Low	- -	- -	-1.82	-1.65	-3.15	-4.62	-1.49	-0.36	-0.2	-0.2
Price/Book Value	- -	- -	-2.37	-4.2	-7.22	-2.18	-1.46	-0.15	-0.02	-0.03
Price/Book Value Average	- -	- -	-5.06	-2.48	-6.22	-3.7	-1.04	-0.7	-0.1	-0.04
Price/Book Value High	- -	- -	-9.09	-4.25	-11.17	-7.27	-1.67	-1.68	-0.26	-0.16
Price/Book Value Low	- -	- -	-1.48	-0.96	-1.87	-2.01	-0.6	-0.11	-0.02	-0.02
Price/Tangible Book Value	- -	- -	1.45	8.85	4.85	2.42	7.84	-1.52	-0.16	-0.2
Price/Tangible Book Value Average	- -	- -	3.08	5.22	4.18	4.1	5.55	-7.34	-0.69	-0.34
Price/Tangible Book Value High	- -	- -	5.54	8.96	7.5	8.06	8.97	-17.59	-1.82	-1.18
Price/Tangible Book Value Low	- -	- -	0.9	2.02	1.25	2.23	3.21	-1.15	-0.13	-0.15
Price/Sales	- -	- -	- -	- -	- -	- -	1,604.7	62.27	6.69	30.42
Price/Sales Average	- -	- -	- -	- -	- -	- -	1,136.59	300.74	28.47	50.34
Price/Sales High	- -	- -	- -	- -	- -	- -	1,835.54	720.31	74.64	176.08
Price/Sales Low	- -	- -	- -	- -	- -	- -	657.04	47.07	5.37	22.25
Price/Cash Flow	- -	- -	-4.16	-8.78	-15.1	-6.53	-4.45	-0.55	-0.21	-0.34
Price/Cash Flow Average	- -	- -	-8.87	-5.18	-13.02	-11.07	-3.15	-2.68	-0.9	-0.56
Price/Cash Flow High	- -	- -	-15.95	-8.9	-23.37	-21.75	-5.09	-6.41	-2.35	-1.96
Price/Cash Flow Low	- -	- -	-2.6	-2	-3.91	-6.01	-1.82	-0.42	-0.17	-0.25
Price/Free Cash Flow Average	- -	- -	-9.1	-5.35	-13.08	-11.13	-3.15	-2.68	-0.9	-0.56
Price/Free Cash Flow High	- -	- -	-16.37	-9.19	-23.48	-21.86	-5.09	-6.41	-2.35	-1.96
Price/Free Cash Flow Low	- -	- -	-2.67	-2.07	-3.92	-6.04	-1.82	-0.42	-0.17	-0.25
EV/Sales Average	- -	- -	- -	- -	- -	- -	871.08	326.94	60.73	176.89
EV/Sales High	- -	- -	- -	- -	- -	- -	1,570.02	746.51	106.9	302.63
EV/Sales Low	- -	- -	- -	- -	- -	- -	391.53	73.28	37.63	148.8
EV/EBITDA Average	- -	0.11	-3.87	-3.26	-7.95	-6.36	-2.05	-2.7	-2.13	-2.27
EV/EBITDA High	- -	0.11	-8.67	-6.27	-16.31	-14.58	-3.7	-6.16	-3.76	-3.89
EV/EBITDA Low	- -	0.11	0.37	-0.68	-0.58	-2.46	-0.92	-0.6	-1.32	-1.91
EV/EBIT Average	- -	0.11	-3.87	-3.24	-7.93	-6.34	-2.05	-2.69	-2.12	-2.26
EV/EBIT High	- -	0.11	-8.66	-6.24	-16.27	-14.54	-3.69	-6.15	-3.74	-3.87
EV/EBIT Low	- -	0.11	0.37	-0.68	-0.58	-2.45	-0.92	-0.6	-1.32	-1.9
Last Price	- -	- -	61.76	233.76	739.2	325.28	343.68	47.2	5.98	1.6
High Price	- -	- -	236.64	236.8	1,144	1,083.84	393.12	546	66.72	9.26
Enterprise Value Average	- -	-1	77	109	652	678	327	451	138	114
Enterprise Value High	- -	-1	173	210	1,339	1,555	589	1,030	242	194
Enterprise Value Low	- -	-1	-7	23	48	262	147	101	85	96

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Shares Outstanding	1	1	1	1	2	2	2	2	3	22
Diluted Weighted Avg Shares	1	1	1	1	1	2	2	2	3	12
Basic Weighted Avg Shares	1	1	1	1	1	2	2	2	3	12
Revenue per Share	- -	- -	- -	- -	- -	- -	0.21	0.76	0.89	0.05
EBITDA per Share	-2.17	-4.78	-21.9	-32.85	-60.59	-64.7	-90.99	-91.9	-25.44	-4.09
Operating Income per Share	-2.17	-4.78	-21.92	-33	-60.73	-64.88	-91.18	-92.07	-25.56	-4.12
Basic EPS, GAAP	-2.17	-4.78	-21.16	-32.38	-60.63	-64.87	-94.67	-98.35	-23.51	-5.73
Basic EPS from Cont Ops	-2.17	-4.78	-21.16	-32.38	-60.63	-64.87	-94.67	-98.35	-23.51	-5.73
Diluted EPS, GAAP	-2.17	-4.78	-21.16	-32.38	-60.63	-64.87	-94.67	-98.35	-23.51	-5.73
Diluted EPS from Cont Ops	-2.17	-4.78	-21.16	-32.38	-60.63	-64.87	-94.67	-98.35	-23.51	-5.73
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-1.32	-2.31	-14.83	-26.62	-48.96	-49.84	-77.3	-85.14	-28.41	-4.72
Free Cash Flow per Basic Share	-1.33	-2.31	-15.21	-27.47	-49.19	-50.11	-77.38	-85.15	-28.41	-4.72
Cash & Equivalents per Share	- -	0.93	46.74	31.85	157.26	141.34	110.64	35.82	11.78	2.33
Book Value per Share	- -	-4.68	-26.03	-55.66	-102.45	-149.1	-235.03	-324.39	-256.47	-58.98
Tangible Book Value per Share	-0.33	-1.03	42.7	26.42	152.52	134.48	43.85	-31.04	-36.73	-7.82

BioXcel Therapeutics, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)